Wohlfert EA et al found that ciglitazone, a synthetic PPAR-γ ligand, exerted the immunoregulatory effect in a model of graft-vs-host disease dependent on the presence of nTregs that expressed PPAR-γ [34]. Here, PPARG is linked to graft versus host disease.